Maher, D.I., Hogarty, D. and Ben Artsi, E. (2022) Response to Letter to the Editor Regarding “Acute Onset Ocular Myasthenia Gravis after Vaccination with the Oxford-Astrazeneca COVID-19 Vaccine”. Orbit, 41, 662-663.
https://doi.org/10.1080/01676830.2022.2087234

has been cited by the following article:

• TITLE: Post-Vaccination Myasthenia Gravis and Vaquez Disease

  AUTHORS: Alassane Mamadou Diop, Ahmadou Bamba Mbodj, Daouda Thioub, Jamil Kawahgi, Maouly Fall

  KEYWORDS: SARS-CoV2, Myasthenia, JAK2

  JOURNAL NAME: Neuroscience and Medicine, Vol.16 No.2, June 25, 2025

  ABSTRACT: We report the case of a 68-year-old patient who developed autoimmune myasthenia 24 hours after receiving the second dose of an inactivated SARS-CoV-2 vaccine (Sinopharm®). This patient, already followed for ischemic heart disease, presented with typical symptoms such as diplopia, bilateral ptosis, and muscle fatigability upon exertion. Investigations revealed the presence of anti-acetylcholine receptor antibodies as well as polycythemia, confirmed by the JAK2 V617F mutation, suggesting an association with a myeloproliferative disorder.